Barry J. Goldstein

20.3k total citations · 5 hit papers
124 papers, 16.0k citations indexed

About

Barry J. Goldstein is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Barry J. Goldstein has authored 124 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 35 papers in Endocrinology, Diabetes and Metabolism and 30 papers in Epidemiology. Recurrent topics in Barry J. Goldstein's work include Protein Tyrosine Phosphatases (34 papers), Metabolism, Diabetes, and Cancer (32 papers) and Adipokines, Inflammation, and Metabolic Diseases (25 papers). Barry J. Goldstein is often cited by papers focused on Protein Tyrosine Phosphatases (34 papers), Metabolism, Diabetes, and Cancer (32 papers) and Adipokines, Inflammation, and Metabolic Diseases (25 papers). Barry J. Goldstein collaborates with scholars based in United States, Japan and Australia. Barry J. Goldstein's co-authors include Timon W. van Haeften, Michael Stümvoll, Kalyankar Mahadev, Xiangdong Wu, Rosario Scalia, Hiroyuki Motoshima, Eiichi Araki, Morris F. White, Faiyaz Ahmad and Li Zhu and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Barry J. Goldstein

123 papers receiving 15.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 diabetes: principles of pathogenesis and therapy

2005 1.8k citations Michael Stümvoll, Barry J. Goldstein et al. The Lancet profile →
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators

2003 1.5k citations Barry J. Goldstein et al. Circulation profile →
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

1991 1.3k citations Eiichi Araki, Barry J. Goldstein et al. profile →
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function

2004 504 citations Barry J. Goldstein et al. The Journal of Clinical Endocrinology & Metabolism profile →
Adiponectin regulates albuminuria and podocyte function in mice

2008 498 citations R. Ouedraogo, Lawrence Chan et al. profile →

Peers

Countries citing papers authored by Barry J. Goldstein

Since Specialization

Citations

This map shows the geographic impact of Barry J. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry J. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry J. Goldstein more than expected).

Fields of papers citing papers by Barry J. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry J. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry J. Goldstein. The network helps show where Barry J. Goldstein may publish in the future.

Co-authorship network of co-authors of Barry J. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Barry J. Goldstein. A scholar is included among the top collaborators of Barry J. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry J. Goldstein. Barry J. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies 2013 ·Diabetes Therapy ·Samuel S. Engel, Elizabeth Round, Gregory T. Golm, Keith D. Kaufman, Barry J. Goldstein	105
2	Assessment of AACE/ACE Recommendations for Initial Dual Antihyperglycemic Therapy Using the Fixed-Dose Combination of Sitagliptin and Metformin Versus Metformin 2013 ·Endocrine Practice ·Samuel S. Engel, Thomas Seck, Gregory T. Golm, Alan G. Meehan, Keith D. Kaufman, Barry J. Goldstein	9
3	Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide 2011 ·Diabetes Research and Clinical Practice ·Thomas Seck, Samuel S. Engel, Debora Williams‐Herman, Christine McCrary Sisk, Gregory T. Golm, Hongwei Wang, Keith D. Kaufman, Barry J. Goldstein	20
4	Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study 2009 ·Current Medical Research and Opinion ·Debora Williams‐Herman, Jeremy Johnson, R. Teng, (unknown), Michael J. Davies, Keith D. Kaufman, Barry J. Goldstein, John M. Amatruda	118
5	Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells 2008 ·Cardiovascular Research ·Kalyankar Mahadev, Xiangdong Wu, (unknown), R. Ouedraogo, Andrea D. Eckhart, Barry J. Goldstein	92
6	The Association ofENPP1K121Q with Diabetes Incidence Is Abolished by Lifestyle Modification in the Diabetes Prevention Program 2008 ·The Journal of Clinical Endocrinology & Metabolism ·Allan F. Moore, Kathleen A. Jablonski, Clinton C. Mason, Jarred B. McAteer, Richard F. Arakaki, Barry J. Goldstein, Steven E. Kahn, Abbas E. Kitabchi, Robert L. Hanson, William C. Knowler, José C. Florez	37
7	Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues 2008 ·Biochemical and Biophysical Research Communications ·(unknown), Hiroyuki Motoshima, (unknown), Motoyuki Igata, Takeshi Matsumura, Tatsuya Kondo, Junji Kawashima, Kenshi Ichinose, Noboru Furukawa, Kouichi Inukai, Shigehiro Katayama, Barry J. Goldstein, Takeshi Nishikawa, Kaku Tsuruzoe, Eiichi Araki	8
8	Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress 2007 ·Circulation ·Ling Tao, Erhe Gao, Xiangying Jiao, Yuexing Yuan, Shuzhuang Li, Theodore A. Christopher, Bernard L. Lopez, Walter Koch, Lawrence Chan, Barry J. Goldstein, Xin L.	391
9	Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity 2007 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Wenqing Wang, Haifeng Zhang, (unknown), Qian Fan, Theodore A. Christopher, Bernard L. Lopez, Ling Tao, Barry J. Goldstein, Feng Gao, Xin L.	149
10	Adiponectin suppresses IκB kinase activation induced by tumor necrosis factor-α or high glucose in endothelial cells: role of cAMP and AMP kinase signaling 2007 ·American Journal of Physiology-Endocrinology and Metabolism ·Xiangdong Wu, Kalyankar Mahadev, (unknown), R. Ouedraogo, Shiqiong Xu, Barry J. Goldstein	62
11	Pathogenesis of Type 2 Diabetes 2007 ·Endocrine Research ·Michael Stümvoll, Barry J. Goldstein, Timon W. van Haeften	45
12	Dual PPAR α/γ Agonists: Promises and Pitfalls in Type 2 Diabetes 2007 ·American Journal of Therapeutics ·Intekhab Ahmed, Kevin Furlong, (unknown), (unknown), Barry J. Goldstein	25
13	Type 2 diabetes: principles of pathogenesis and therapy breakdown → 2005 ·The Lancet ·Michael Stümvoll, Barry J. Goldstein, Timon W. van Haeften	1848
14	Depot-Specific Variation in Protein-Tyrosine Phosphatase Activities in Human Omental and Subcutaneous Adipose Tissue: A Potential Contribution to Differential Insulin Sensitivity 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Xiangdong Wu, Johan Hoffstedt, (unknown), Reetu R. Singh, (unknown), (unknown), Li Zhu, Pauline K. Park, Peter Arner, Barry J. Goldstein	51
15	Tyrosine Phosphoprotein Phosphatases 1998 ·Barry J. Goldstein	4
16	Dexamethasone, OB Gene, and Leptin in Humans; Effect of Exogenous Hyperinsulinemia¹ 1997 ·The Journal of Clinical Endocrinology & Metabolism ·Jerzy W. Kolaczynski, Barry J. Goldstein, Robert V. Considine	48
17	The Transmembrane Protein-tyrosine Phosphatase LAR Modulates Signaling by Multiple Receptor Tyrosine Kinases 1996 ·Journal of Biological Chemistry ·Donald T. Kulas, Barry J. Goldstein, Robert A. Mooney	108
18	Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells 1996 ·Cellular Signalling ·(unknown), Wei-Ren Zhang, Barry J. Goldstein	45
19	Identification of skeletal muscle protein-tyrosine phosphatases by amplification of conserved cDNA sequences 1991 ·Biochemical and Biophysical Research Communications ·Wei-Ren Zhang, Barry J. Goldstein	21
20	Variation in Insulin Receptor Messenger Ribonucleic Acid Expression in Human and Rodent Tissues 1987 ·Molecular Endocrinology ·Barry J. Goldstein, Dirk Müller‐Wieland, C. Ronald Kahn	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact